Expression Profile, Prognostic Value, and Therapeutic Potential of NSD2 in Pan-Cancer: A Systematic Analysis Integrating Multi-Omics Data
This study systematically demonstrates that NSD2 is a pan-cancer biomarker with significant diagnostic and prognostic value, characterized by its overexpression in advanced tumors, association with poor survival and immune evasion, and potential as a therapeutic target for agents like H-7 and thapsigargin.